Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology

The Great Masquerader: Red Flags and Misdiagnosis

At a Glance

Amyloidosis is frequently misdiagnosed because its symptoms mimic common diseases. Key early red flags include bilateral carpal tunnel syndrome, a ruptured biceps tendon, unexplained digestive issues, and thickened heart walls that are often mistaken for standard heart failure.

Amyloidosis is often called a “great masquerader” because its symptoms look like many other common diseases. Understanding why it is so frequently misdiagnosed can help you piece together your own medical history and advocate for the right tests.

Why Your Heart Symptoms Were Confusing

If you have cardiac amyloidosis (amyloid in the heart), your initial diagnosis may have been HFpEF (Heart Failure with Preserved Ejection Fraction) or HCM (Hypertrophic Cardiomyopathy) [1][2].

  • The Mimic: In all three conditions, the walls of the heart appear thick on an ultrasound. In HCM, the muscle itself is thick due to genetics. In amyloidosis, the walls are “pseudo-thickened” because amyloid proteins have leaked into the spaces between the cells, making the heart stiff and heavy [1][3].
  • The Difference: While a standard ultrasound might show “preserved” pumping (ejection fraction), specialized tests are needed to reveal the truth. Strain imaging (a special type of echocardiogram) can reveal the specific “cherry on top” pattern of amyloid. Alternatively, a bone scintigraphy (PYP) scan positively identifies ATTR amyloidosis by showing radiotracer absorption directly in the heart muscle [4][2].

The “Orphan” Orthopedic Red Flags

One of the most striking aspects of amyloidosis—specifically the ATTR type—is that the first signs often appear years before any heart or nerve trouble. These are often treated as isolated orthopedic issues rather than parts of a systemic disease.

  • Bilateral Carpal Tunnel Syndrome: Up to 75% of patients with ATTR amyloidosis have carpal tunnel syndrome, often in both hands [5]. Crucially, this typically occurs 5 to 9 years before a heart diagnosis is made [6].
  • Spinal Stenosis: Narrowing of the lower spine (lumbar spinal stenosis) is another major red flag, often appearing about 19 months before systemic symptoms become clear [7].
  • The “Popeye” Sign: A spontaneous rupture of the biceps tendon (which creates a bulge in the upper arm) is a highly specific warning sign for ATTR amyloidosis [8][9].

Neurological and “Automatic” Warning Signs

In the hereditary form of the disease (ATTRv), the proteins often attack the nerves first.

  • Small Fiber Neuropathy: This often starts as burning, tingling, or numbness in the toes and feet. It specifically affects the “small fibers” that carry pain and temperature signals [10].
  • Autonomic Dysfunction: This refers to the “automatic” functions of your body. Red flags include:
    • Orthostatic Hypotension: A sudden drop in blood pressure when you stand up, leading to dizziness or fainting [11][12].
    • Gastrointestinal (GI) Issues: Feeling full after only a few bites of food (early satiety), unexplained weight loss, or alternating bouts of diarrhea and constipation [13][14].
    • Sweating Changes: A sudden inability to sweat or unusual sweating patterns [15].

Summary of Diagnostic Timelines

Symptom Typical Lead Time Before Diagnosis
Carpal Tunnel (Both Hands) 5 to 9 Years [6]
Spinal Stenosis ~1.5 Years [7]
Heart Failure Symptoms Months to Years [16]

By recognizing that these seemingly unrelated issues—from your wrist surgery to your “stiff” heart—are actually connected, you and your care team can better monitor the disease and tailor your treatment [5][9].

Common questions in this guide

Why is cardiac amyloidosis frequently misdiagnosed?
Cardiac amyloidosis causes amyloid proteins to build up between heart cells, making the heart walls look thick on a standard ultrasound. This thickening closely mimics common conditions like heart failure (HFpEF) or hypertrophic cardiomyopathy, requiring specialized imaging like a PYP scan to correctly diagnose.
Can carpal tunnel syndrome be a sign of amyloidosis?
Yes, developing carpal tunnel syndrome in both hands is a major early warning sign for ATTR amyloidosis. This often occurs 5 to 9 years before any significant heart or neurological symptoms are detected.
What is the "Popeye" sign in amyloidosis?
The "Popeye" sign refers to a spontaneous rupture of the biceps tendon, which creates a noticeable bulge in the upper arm. This specific type of tendon injury is a highly distinct red flag for ATTR amyloidosis.
What are the neurological warning signs of hereditary amyloidosis?
Hereditary amyloidosis often attacks the nervous system first, causing burning or tingling in the feet known as small fiber neuropathy. It can also disrupt automatic bodily functions, leading to severe dizziness when standing, early fullness when eating, and changes in sweating.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that I have a history of carpal tunnel syndrome, could this be a 'red flag' for my current cardiac or neurological issues?
  2. 2.How can we distinguish my heart symptoms from more common conditions like HFpEF or HCM?
  3. 3.Should I have a specific test, like bone scintigraphy (PYP scan) or a specialized cardiac MRI, to look for amyloid deposits?
  4. 4.Are my gastrointestinal issues, like feeling full quickly or unexplained diarrhea, related to my amyloidosis diagnosis?
  5. 5.Does my history of spinal stenosis or biceps tendon rupture change how you view my overall prognosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Amyloid heart disease: genetics translated into disease-modifying therapy.

    Sperry BW, Tang WHW

    Heart (British Cardiac Society) 2017; (103(11)):812-817 doi:10.1136/heartjnl-2016-309914.

    PMID: 28255101
  2. 2

    Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.

    Tini G, Sessarego E, Benenati S, et al.

    European journal of clinical investigation 2021; (51(12)):e13665 doi:10.1111/eci.13665.

    PMID: 34390490
  3. 3

    Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.

    Smiley DA, Rodriguez CM, Maurer MS

    Cardiology clinics 2022; (40(4)):541-558 doi:10.1016/j.ccl.2022.06.008.

    PMID: 36210137
  4. 4

    Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

    Castano A, Haq M, Narotsky DL, et al.

    JAMA cardiology 2016; (1(8)):880-889 doi:10.1001/jamacardio.2016.2839.

    PMID: 27557400
  5. 5

    Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.

    Cappelli F, Zampieri M, Fumagalli C, et al.

    Journal of internal medicine 2021; (289(6)):831-839 doi:10.1111/joim.13200.

    PMID: 33615623
  6. 6

    Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.

    Milandri A, Farioli A, Gagliardi C, et al.

    European journal of heart failure 2020; (22(3)):507-515 doi:10.1002/ejhf.1742.

    PMID: 31975495
  7. 7

    Patient Journey to Transthyretin Cardiac Amyloidosis Diagnosis　- A Japanese Claims Database Study.

    Minamisawa M, Konishi H, Kitano Y, et al.

    Circulation journal : official journal of the Japanese Circulation Society 2025; (89(4)):432-441 doi:10.1253/circj.CJ-24-0666.

    PMID: 39880606
  8. 8

    Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Musculoskeletal symptoms: Red Flags in the Rheumatology/Orthopedics Practice Setting.

    Bardin T, Bigorre N, Hachulla E, et al.

    Joint bone spine 2025; 106028 doi:10.1016/j.jbspin.2025.106028.

    PMID: 41456728
  9. 9

    Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease.

    Perfetto F, Zampieri M, Bandini G, et al.

    Biomedicines 2022; (10(12)) doi:10.3390/biomedicines10123226.

    PMID: 36551982
  10. 10

    Familial Amyloid Polyneuropathy.

    Çakar A, Durmuş-Tekçe H, Parman Y

    Noro psikiyatri arsivi 2019; (56(2)):150-156 doi:10.29399/npa.23502.

    PMID: 31223250
  11. 11

    Systemic Amyloid Light Chain Amyloidosis With Repeated Syncope Due to Severe Orthostatic Hypotension Caused by Autonomic Neuropathy: A Case Report.

    Mori Y, Kenzaka T

    Cureus 2024; (16(11)):e73320 doi:10.7759/cureus.73320.

    PMID: 39655131
  12. 12

    Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.

    Chiaro G, Stancanelli C, Koay S, et al.

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2024; (34(3)):341-352 doi:10.1007/s10286-024-01038-z.

    PMID: 38769233
  13. 13

    Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis.

    Krauß LU, Schmid S, Mester P, et al.

    Journal of gastrointestinal and liver diseases : JGLD 2023; (32(4)):497-506 doi:10.15403/jgld-5107.

    PMID: 38147621
  14. 14

    Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.

    Hasib Sidiqi M, Gertz MA

    Blood cancer journal 2021; (11(5)):90 doi:10.1038/s41408-021-00483-7.

    PMID: 33993188
  15. 15

    Sudoscan in ATTRv Amyloidosis: A Potential Marker of Disease Progression?

    Romano A, Guglielmino V, Vitali F, et al.

    Neurology and therapy 2025; (14(3)):787-800 doi:10.1007/s40120-025-00721-1.

    PMID: 40091132
  16. 16

    Amyloidosis from the patient perspective: the French daily impact of amyloidosis study.

    Damy T, Adams D, Bridoux F, et al.

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2022; (29(3)):165-174 doi:10.1080/13506129.2022.2035354.

    PMID: 35144512

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider if you are experiencing symptoms or suspect you may have amyloidosis.

Get notified when new evidence is published on Amyloidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.